{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:44:29Z","timestamp":1783741469748,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3400504"],"award-info":[{"award-number":["2022YFC3400504"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Strategic Priority Research Program of the Chinese Academy of sciences","award":["XDB0830200"],"award-info":[{"award-number":["XDB0830200"]}]},{"name":"Strategic Priority Research Program of the Chinese Academy of sciences","award":["XDB0830203"],"award-info":[{"award-number":["XDB0830203"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["T2225002"],"award-info":[{"award-number":["T2225002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82204278"],"award-info":[{"award-number":["82204278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"SIMM-SHUTCM Traditional Chinese Medicine Innovation Joint Research Program","award":["E2G805H"],"award-info":[{"award-number":["E2G805H"]}]},{"name":"Large-scale Protein Preparation System at the National Facility for Protein Science in Shanghai (NFPS), Shanghai Advanced Research Institute, Chinese Academy of Science, China"},{"name":"Shanghai Supercomputer Center"},{"name":"Shanghai Municipal Science and Technology Major Project"},{"name":"Postdoctoral Fellowship Program of CPSF","award":["GZC20232846"],"award-info":[{"award-number":["GZC20232846"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2024M763419"],"award-info":[{"award-number":["2024M763419"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Youth Innovation Promotion Association CAS","award":["2023296"],"award-info":[{"award-number":["2023296"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11030-024-11095-1","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T07:53:40Z","timestamp":1739433220000},"page":"6107-6120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Discovery of novel covalent stabilizers for p53 Y220C using structure-based drug discovery methods"],"prefix":"10.1007","volume":"29","author":[{"given":"Yiming","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xutong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"11095_CR1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000919","author":"AC Joerger","year":"2010","unstructured":"Joerger AC, Fersht AR (2010) The tumor suppressor p53: from structures to drug discovery. Cold Spring Harbor Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a000919","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"11095_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev-biochem-060815-014710","volume":"85","author":"AC Joerger","year":"2016","unstructured":"Joerger AC, Fersht AR (2016) The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches. Ann Rev Biochem 85:375\u2013404. https:\/\/doi.org\/10.1146\/annurev-biochem-060815-014710","journal-title":"Ann Rev Biochem"},{"key":"11095_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.semcancer.2020.07.005","volume-title":"Seminars in cancer biology","author":"MJ Duffy","year":"2022","unstructured":"Duffy MJ, Synnott NC, O\u2019Grady S, Crown J (2022) Targeting p53 for the treatment of cancer. Seminars in cancer biology. Elsevier, Amsterdam, pp 58\u201367. https:\/\/doi.org\/10.1016\/j.semcancer.2020.07.005"},{"key":"11095_CR4","doi-asserted-by":"publisher","first-page":"jcs237453","DOI":"10.1242\/jcs.237453","volume":"133","author":"J Blagih","year":"2020","unstructured":"Blagih J, Buck MD, Vousden KH (2020) p53, cancer and the immune response. J Cell Sci 133:jcs237453. https:\/\/doi.org\/10.1242\/jcs.237453","journal-title":"J Cell Sci"},{"key":"11095_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-02396-8","volume":"21","author":"HE Marei","year":"2021","unstructured":"Marei HE, Althani A, Afifi N, Hasan A, Caceci T, Pozzoli G, Morrione A, Giordano A, Cenciarelli C (2021) p53 signaling in cancer progression and therapy. Cancer Cell Int 21:1\u201315. https:\/\/doi.org\/10.1186\/s12935-021-02396-8","journal-title":"Cancer Cell Int"},{"key":"11095_CR6","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.7150\/thno.81847","volume":"13","author":"C Marvalim","year":"2023","unstructured":"Marvalim C, Datta A, Lee SC (2023) Role of p53 in breast cancer progression: an insight into p53 targeted therapy. Theranostics 13:1421. https:\/\/doi.org\/10.7150\/thno.81847","journal-title":"Theranostics"},{"key":"11095_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.critrevonc.2004.07.002","volume":"52","author":"A Feki","year":"2004","unstructured":"Feki A, Irminger-Finger I (2004) Mutational spectrum of p53 mutations in primary breast and ovarian tumors. Critic Rev Oncol\/Hematol 52:103\u2013116. https:\/\/doi.org\/10.1016\/j.critrevonc.2004.07.002","journal-title":"Critic Rev Oncol\/Hematol"},{"key":"11095_CR8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/humu.22552","volume":"35","author":"B Leroy","year":"2014","unstructured":"Leroy B, Anderson M, Soussi T (2014) TP53 mutations in human cancer: database reassessment and prospects for the next decade. Human Mutat 35:672\u2013688. https:\/\/doi.org\/10.1002\/humu.22552","journal-title":"Human Mutat"},{"key":"11095_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/humu.10081","volume":"19","author":"M Olivier","year":"2002","unstructured":"Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Human Mutat 19:607\u2013614. https:\/\/doi.org\/10.1002\/humu.10081","journal-title":"Human Mutat"},{"key":"11095_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nrc2763","volume":"9","author":"CJ Brown","year":"2009","unstructured":"Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP (2009) Awakening guardian angels: drugging the p53 pathway. Nat Rev Cancer 9:862\u2013873. https:\/\/doi.org\/10.1038\/nrc2763","journal-title":"Nat Rev Cancer"},{"key":"11095_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb2641","volume":"15","author":"PA Muller","year":"2013","unstructured":"Muller PA, Vousden KH (2013) p53 mutations in cancer. Nat Cell Biol 15:2\u20138. https:\/\/doi.org\/10.1038\/ncb2641","journal-title":"Nat Cell Biol"},{"key":"11095_CR12","doi-asserted-by":"publisher","first-page":"14338","DOI":"10.1073\/pnas.94.26.14338","volume":"94","author":"AN Bullock","year":"1997","unstructured":"Bullock AN, Henckel J, DeDecker BS, Johnson CM, Nikolova PV, Proctor MR, Lane DP, Fersht AR (1997) Thermodynamic stability of wild-type and mutant p53 core domain. Proceed Nat Acad Sci 94:14338\u201314342. https:\/\/doi.org\/10.1073\/pnas.94.26.14338","journal-title":"Proceed Nat Acad Sci"},{"key":"11095_CR13","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1073\/pnas.0607286103","volume":"103","author":"AC Joerger","year":"2006","unstructured":"Joerger AC, Ang HC, Fersht AR (2006) Structural basis for understanding oncogenic p53 mutations and designing rescue drugs. Proceed Nat Acad Sci 103:15056\u201315061. https:\/\/doi.org\/10.1073\/pnas.0607286103","journal-title":"Proceed Nat Acad Sci"},{"key":"11095_CR14","doi-asserted-by":"publisher","first-page":"10360","DOI":"10.1073\/pnas.0805326105","volume":"105","author":"FM Boeckler","year":"2008","unstructured":"Boeckler FM, Joerger AC, Jaggi G, Rutherford TJ, Veprintsev DB, Fersht AR (2008) Targeted rescue of a destabilized mutant of p53 by an in silico screened drug. Proceed Nat Acad Sci 105:10360\u201310365. https:\/\/doi.org\/10.1073\/pnas.0805326105","journal-title":"Proceed Nat Acad Sci"},{"key":"11095_CR15","doi-asserted-by":"publisher","first-page":"e1002238","DOI":"10.1371\/journal.pcbi.1002238","volume":"7","author":"\u00d6 Demir","year":"2011","unstructured":"Demir \u00d6, Baronio R, Salehi F, Wassman CD, Hall L, Hatfield GW, Chamberlin R, Kaiser P, Lathrop RH, Amaro RE (2011) Ensemble-based computational approach discriminates functional activity of p53 cancer and rescue mutants. PLoS Comput Biol 7:e1002238. https:\/\/doi.org\/10.1371\/journal.pcbi.1002238","journal-title":"PLoS Comput Biol"},{"key":"11095_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1146\/annurev.biochem.77.060806.091238","volume":"77","author":"AC Joerger","year":"2008","unstructured":"Joerger AC, Fersht AR (2008) Structural biology of the tumor suppressor p53. Ann Rev Biochem 77:557\u2013582. https:\/\/doi.org\/10.1146\/annurev.biochem.77.060806.091238","journal-title":"Ann Rev Biochem"},{"key":"11095_CR17","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1038\/sj.onc.1210291","volume":"26","author":"A Joerger","year":"2007","unstructured":"Joerger A, Fersht AR (2007) Structure\u2013function\u2013rescue: the diverse nature of common p53 cancer mutants. Oncogene 26:2226\u20132242. https:\/\/doi.org\/10.1038\/sj.onc.1210291","journal-title":"Oncogene"},{"key":"11095_CR18","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.4155\/fmc-2019-0181","volume":"11","author":"MR Bauer","year":"2019","unstructured":"Bauer MR, Jones RN, Tareque RK, Springett B, Dingler FA, Verduci L, Patel KJ, Fersht AR, Joerger AC, Spencer J (2019) A structure-guided molecular chaperone approach for restoring the transcriptional activity of the p53 cancer mutant Y220C. Future Med Chem 11:2491\u20132504. https:\/\/doi.org\/10.4155\/fmc-2019-0181","journal-title":"Future Med Chem"},{"key":"11095_CR19","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1021\/acsptsci.2c00164","volume":"5","author":"JR Stephenson Clarke","year":"2022","unstructured":"Stephenson Clarke JR, Douglas LR, Duriez PJ, Balourdas D-I, Joerger AC, Khadiullina R, Bulatov E, Baud MG (2022) Discovery of nanomolar-affinity pharmacological chaperones stabilizing the oncogenic p53 mutant Y220C. ACS Pharmacol Translaat Sci 5:1169\u20131180. https:\/\/doi.org\/10.1021\/acsptsci.2c00164","journal-title":"ACS Pharmacol Translaat Sci"},{"key":"11095_CR20","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1021\/jm8008597","volume":"52","author":"MH Potashman","year":"2009","unstructured":"Potashman MH, Duggan ME (2009) Covalent modifiers: an orthogonal approach to drug design. J Med Chem 52:1231\u20131246. https:\/\/doi.org\/10.1021\/jm8008597","journal-title":"J Med Chem"},{"key":"11095_CR21","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/pro.507","volume":"19","author":"JL Kaar","year":"2010","unstructured":"Kaar JL, Basse N, Joerger AC, Stephens E, Rutherford TJ, Fersht AR (2010) Stabilization of mutant p53 via alkylation of cysteines and effects on DNA binding. Protein Sci 19:2267\u20132278. https:\/\/doi.org\/10.1002\/pro.507","journal-title":"Protein Sci"},{"key":"11095_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bmcl.2013.10.003","volume":"24","author":"R Mah","year":"2014","unstructured":"Mah R, Thomas JR, Shafer CM (2014) Drug discovery considerations in the development of covalent inhibitors. Bioorgan Med Chem Lett 24:33\u201339. https:\/\/doi.org\/10.1016\/j.bmcl.2013.10.003","journal-title":"Bioorgan Med Chem Lett"},{"key":"11095_CR23","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.3390\/molecules20021984","volume":"20","author":"HM Kumalo","year":"2015","unstructured":"Kumalo HM, Bhakat S, Soliman ME (2015) Theory and applications of covalent docking in drug discovery: merits and pitfalls. Molecules 20:1984\u20132000. https:\/\/doi.org\/10.3390\/molecules20021984","journal-title":"Molecules"},{"key":"11095_CR24","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1021\/acs.molpharmaceut.6b00302","volume":"13","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhang D, Tian H, Jiao Y, Shi Z, Ran T, Liu H, Lu S, Xu A, Qiao X (2016) Identification of covalent binding sites targeting cysteines based on computational approaches. Mole Pharmaceut 13:3106\u20133118. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00302","journal-title":"Mole Pharmaceut"},{"key":"11095_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/17460441.2021.1832079","volume":"16","author":"TA Baillie","year":"2021","unstructured":"Baillie TA (2021) Approaches to mitigate the risk of serious adverse reactions in covalent drug design. Expert Opin Drug Discov 16:275\u2013287. https:\/\/doi.org\/10.1080\/17460441.2021.1832079","journal-title":"Expert Opin Drug Discov"},{"key":"11095_CR26","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","volume":"21","author":"L Boike","year":"2022","unstructured":"Boike L, Henning NJ, Nomura DK (2022) Advances in covalent drug discovery. Nat Rev Drug Discov 21:881\u2013898. https:\/\/doi.org\/10.1038\/s41573-022-00542-z","journal-title":"Nat Rev Drug Discov"},{"key":"11095_CR27","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55:6582\u20136594. https:\/\/doi.org\/10.1021\/jm300687e","journal-title":"J Med Chem"},{"key":"11095_CR28","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1021\/ci500118s","volume":"54","author":"K Zhu","year":"2014","unstructured":"Zhu K, Borrelli KW, Greenwood JR, Day T, Abel R, Farid RS, Harder E (2014) Docking covalent inhibitors: a parameter free approach to pose prediction and scoring. J Chem Inform Model 54:1932\u20131940. https:\/\/doi.org\/10.1021\/ci500118s","journal-title":"J Chem Inform Model"},{"key":"11095_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-024-10918-5","author":"G Qiu","year":"2024","unstructured":"Qiu G, Yu L, Jia L, Cai Y, Chen Y, Jin J, Xu L, Zhu J (2024) Identification of novel covalent JAK3 inhibitors through consensus scoring virtual screening: integration of common feature pharmacophore and covalent docking. Mole Divers. https:\/\/doi.org\/10.1007\/s11030-024-10918-5","journal-title":"Mole Divers"},{"key":"11095_CR30","doi-asserted-by":"publisher","first-page":"108132","DOI":"10.1016\/j.compbiolchem.2024.108132","volume":"112","author":"DK Patel","year":"2024","unstructured":"Patel DK, Kumar H, Sobhia ME (2024) Exploring the binding dynamics of covalent inhibitors within active site of PLpro in SARS-CoV-2. Comput Biol Chem 112:108132. https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108132","journal-title":"Comput Biol Chem"},{"key":"11095_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/cbdd.13991","volume":"99","author":"L Yu","year":"2022","unstructured":"Yu L, Jiang Y, Xu L, Jin J, Pei Z, Zhu J (2022) Theoretical study of myriocin-binding mechanism targeting serine palmitoyltransferase. Chem Biol Drug Des 99:373\u2013381. https:\/\/doi.org\/10.1111\/cbdd.13991","journal-title":"Chem Biol Drug Des"},{"key":"11095_CR32","doi-asserted-by":"publisher","first-page":"E4758","DOI":"10.1073\/pnas.1800690115","volume":"115","author":"P Robustelli","year":"2018","unstructured":"Robustelli P, Piana S, Shaw DE (2018) Developing a molecular dynamics force field for both folded and disordered protein states. Proceed Nat Acad Sci 115:E4758\u2013E4766. https:\/\/doi.org\/10.1073\/pnas.1800690115","journal-title":"Proceed Nat Acad Sci"},{"key":"11095_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100275a","volume":"51","author":"T Hou","year":"2011","unstructured":"Hou T, Wang J, Li Y, Wang W (2011) Assessing the performance of the MM\/PBSA and MM\/GBSA Methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inform Model 51:69\u201382. https:\/\/doi.org\/10.1021\/ci100275a","journal-title":"J Chem Inform Model"},{"key":"11095_CR34","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/jcc.21372","volume":"31","author":"G Rastelli","year":"2010","unstructured":"Rastelli G, Del Rio A, Degliesposti G, Sgobba M (2010) Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA. J Comput Chem 31:797\u2013810. https:\/\/doi.org\/10.1002\/jcc.21372","journal-title":"J Comput Chem"},{"key":"11095_CR35","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","volume":"53","author":"JB Baell","year":"2010","unstructured":"Baell JB, Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53:2719\u20132740. https:\/\/doi.org\/10.1021\/jm901137j","journal-title":"J Med Chem"},{"key":"11095_CR36","doi-asserted-by":"publisher","first-page":"10875","DOI":"10.1021\/acsami.1c25175","volume":"14","author":"CS Ong","year":"2022","unstructured":"Ong CS, Oor JZ, Tan SJ, Chew JW (2022) Enantiomeric separation of racemic mixtures using chiral-selective and organic-solvent-resistant thin-film composite membranes. ACS Appl Mater Interfaces 14:10875\u201310885. https:\/\/doi.org\/10.1021\/acsami.1c25175","journal-title":"ACS Appl Mater Interfaces"},{"key":"11095_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1229696","author":"S Zhou","year":"2023","unstructured":"Zhou S, Chai D, Wang X, Neeli P, Yu X, Davtyan A, Young K, Li Y (2023) AI-powered discovery of a novel p53\u2013Y220C reactivator. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2023.1229696","journal-title":"Front Oncol"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11095-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-024-11095-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-024-11095-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:28:52Z","timestamp":1763728132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-024-11095-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11095"],"URL":"https:\/\/doi.org\/10.1007\/s11030-024-11095-1","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}